Cancer Research Cell Death Mechanisms and Cancer Therapy Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Correction for Kenanova et al., Cancer Res 65 (2) 622-631.
Cancer Research 67, 844, January 15, 2007. doi: 10.1158/0008-5472.CAN-67-2-COR1
© 2007 American Association for Cancer Research
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Corrections

Correction: Pharmacokinetics of Anti-CEA scFv-Fc and Variants

In the article on pharmacokinetics of anti-CEA scFv-Fc and variants in the January 15, 2005 issue of Cancer Research (1), there are three errors in Table 1 . In the first line under 131I-scFv-Fc I253A (Blood), the value under the fifth column (6 hours) should be 22.5 (0.54); in the first line under 125I-scFv-Fc H310A (Blood), the value under the fourth column (4 hours) should be 25.0 (0.74); and in the first line under 131I-scFv-Fc H310A/H435Q (Blood), the value under the sixth column (12 hours) should be 10.7 (0.46). The corrected Table appears below.


View this table:
[in this window]
[in a new window]

  		Table 1. Biodistribution of 125I and 131I-labeled T84.66 scFv-Fc fragments in BALB/c mice

 
References

  1. Kenanova V, Olafsen T, Crow DM, Sundaresan G, Subbarayan M, Carter NH, Ikle DN, Yazaki PJ, Chatziioannou AF, Gambhir SS, Williams LE, Shively JE, Colcher D, Raubitschek AA, Wu AM. Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti–carcinoembryonic antigen single-chain Fv-Fc antibody fragments. Cancer Res 2005;65:622–31.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online